Chartwell Investment Partners’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$8.68M Buy
201,652
+41,089
+26% +$1.83M 0.3% 105
2024
Q2
$7.26M Buy
160,563
+15,776
+11% +$819K 0.25% 130
2024
Q1
$9.04M Sell
144,787
-36,019
-20% -$2.16M 0.31% 107
2023
Q4
$10.1M Sell
180,806
-6,466
-3% -$322K 0.36% 99
2023
Q3
$9.88M Sell
187,272
-9,090
-5% -$530K 0.38% 82
2023
Q2
$12.6M Sell
196,362
-3,705
-2% -$211K 0.46% 57
2023
Q1
$10.7M Buy
200,067
+67,404
+51% +$3.91M 0.41% 75
2022
Q4
$7.1M Buy
+132,663
New +$6.85M 0.28% 126

Other funds holding ENOV

Chartwell Investment Partners's ENOV Position: Q3 2024 in Review

Chartwell Investment Partners increased its Enovis (ENOV) stake by 26% in Q3 2024, buying an estimated $1.83M and bringing the position to 201,652 shares worth $8.68M. The position accounts for 0.3% of the portfolio, ranked #105.

Chartwell Investment Partners first reported a position in ENOV in Q4 2022 and has held it in 8 quarters since. The position peaked at $12.6M in Q2 2023. 283 funds tracked by Wall St. Rank hold ENOV as of Q3 2024.

  • Chartwell Investment Partners held 201,652 shares of Enovis worth $8.68M as of Q3 2024.
  • Chartwell Investment Partners bought 41,089 Enovis shares in Q3 2024, an estimated $1.83M.
  • Enovis made up 0.3% of Chartwell Investment Partners's portfolio in Q3 2024, its #105 holding.
  • Chartwell Investment Partners first reported a position in Enovis in Q4 2022 and has held it in 8 quarters since.
  • Chartwell Investment Partners's Enovis position peaked at $12.6M in Q2 2023.
  • 283 funds tracked by Wall St. Rank held Enovis as of Q3 2024.

Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.